Vinay P, Prud'homme M, Vinet B, Gougoux A, Léveillée M, St-Louis G, Lapierre L, Piette Y
Clin Invest Med. 1986;9(3):160-6.
The present study was undertaken to evaluate whether the acid-base status influences the rate of acetate metabolism in patients chronically hemodialyzed against acetate. Ten patients (5 "intolerant" and 5 "tolerant" to acetate) received in a randomized order and for three consecutive dialyses each of the six following infusions in the venous line of the dialyzer: NaHCO3 (22, 44 or 88 mEq/h), NaCl (22 or 44 mEq/h) or Dextrose 5% in water (30 mmol/h). Plasma acetate was measured at the end of the dialysis. Bicarbonate infusions increased significantly blood pH and plasma bicarbonate but did not change the plasma acetate concentration at the end of dialysis. We conclude that the rate of acetate metabolism is not modified by changes in the acid-base status within the range usually observed in hemodialyzed patients. A significant hypoxemia per dialysis was noted only in AT patients with lower plasma acetate and rapid acetate metabolism. We conclude that acetate metabolism (and not plasma acetate concentration) plays a significant role in dialysis-induced hypoxemia.
本研究旨在评估酸碱状态是否会影响长期接受醋酸盐血液透析患者的醋酸盐代谢速率。十名患者(5名对醋酸盐“不耐受”,5名对醋酸盐“耐受”)按随机顺序接受治疗,在透析器静脉管路中连续三次透析,每次透析接受以下六种输注液中的一种:碳酸氢钠(22、44或88 mEq/h)、氯化钠(22或44 mEq/h)或5%葡萄糖水溶液(30 mmol/h)。在透析结束时测量血浆醋酸盐。输注碳酸氢盐显著提高了血液pH值和血浆碳酸氢盐,但在透析结束时并未改变血浆醋酸盐浓度。我们得出结论,在血液透析患者通常观察到的范围内,酸碱状态的变化不会改变醋酸盐代谢速率。仅在血浆醋酸盐水平较低且醋酸盐代谢较快的不耐受醋酸盐患者中,每次透析出现明显的低氧血症。我们得出结论,醋酸盐代谢(而非血浆醋酸盐浓度)在透析引起的低氧血症中起重要作用。